BR0214998A - Combinações farmacêuticas de agonistas do receptor da adenosina a-2a e do receptor adrenérgico beta-2 - Google Patents
Combinações farmacêuticas de agonistas do receptor da adenosina a-2a e do receptor adrenérgico beta-2Info
- Publication number
- BR0214998A BR0214998A BR0214998-2A BR0214998A BR0214998A BR 0214998 A BR0214998 A BR 0214998A BR 0214998 A BR0214998 A BR 0214998A BR 0214998 A BR0214998 A BR 0214998A
- Authority
- BR
- Brazil
- Prior art keywords
- adenosine
- receptor
- beta
- pharmaceutical combinations
- adrenergic receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
"COMBINAçõES FARMACêUTICAS DE AGONISTAS DO RECEPTOR DA ADENOSINA A-2A E DO RECEPTOR ADRENéRGICO BETA-2". A presente invenção refere-se a uma combinação que compreende (a) um agonista do receptor A~ 2a~ da adenosina como definido neste relatório e (b) um agonista do receptor adrenérgico <225>2, para a administração de forma simultânea, em seq³ência ou separada, através da via de inalação no tratamento de uma doença obstrutiva ou de outra doença inflamatória das vias aéreas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129270.5A GB0129270D0 (en) | 2001-12-06 | 2001-12-06 | Pharmaceutical combination |
| PCT/IB2002/005057 WO2003047598A1 (en) | 2001-12-06 | 2002-11-28 | Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0214998A true BR0214998A (pt) | 2004-12-28 |
Family
ID=9927164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0214998-2A BR0214998A (pt) | 2001-12-06 | 2002-11-28 | Combinações farmacêuticas de agonistas do receptor da adenosina a-2a e do receptor adrenérgico beta-2 |
Country Status (37)
| Country | Link |
|---|---|
| EP (1) | EP1455799B1 (pt) |
| JP (1) | JP2005513041A (pt) |
| KR (1) | KR100685557B1 (pt) |
| CN (1) | CN1856314A (pt) |
| AP (2) | AP2004003082A0 (pt) |
| AR (1) | AR037634A1 (pt) |
| AT (1) | ATE293982T1 (pt) |
| AU (1) | AU2002351066B2 (pt) |
| BR (1) | BR0214998A (pt) |
| CA (1) | CA2469085A1 (pt) |
| CO (1) | CO5580752A2 (pt) |
| DE (1) | DE60203934T2 (pt) |
| DK (1) | DK1455799T3 (pt) |
| EA (1) | EA200400639A1 (pt) |
| EC (1) | ECSP045132A (pt) |
| ES (1) | ES2239728T3 (pt) |
| GB (1) | GB0129270D0 (pt) |
| GT (1) | GT200200258A (pt) |
| HN (1) | HN2002000348A (pt) |
| HR (1) | HRP20040517A2 (pt) |
| HU (1) | HUP0402540A3 (pt) |
| IS (1) | IS7280A (pt) |
| MA (1) | MA27150A1 (pt) |
| MX (1) | MXPA04005506A (pt) |
| NO (1) | NO20042839L (pt) |
| NZ (1) | NZ533054A (pt) |
| OA (1) | OA12738A (pt) |
| PA (1) | PA8560701A1 (pt) |
| PE (1) | PE20030834A1 (pt) |
| PL (1) | PL370739A1 (pt) |
| PT (1) | PT1455799E (pt) |
| SV (1) | SV2004001426A (pt) |
| TN (1) | TNSN04101A1 (pt) |
| TW (1) | TWI256388B (pt) |
| UY (1) | UY27566A1 (pt) |
| WO (1) | WO2003047598A1 (pt) |
| ZA (1) | ZA200403966B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100785969B1 (ko) * | 2004-05-12 | 2007-12-14 | 동아제약주식회사 | Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성폐질환 예방 또는 치료제 |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| JP2016518388A (ja) | 2013-04-30 | 2016-06-23 | オティトピック インク． | 乾燥粉末配合および使用方法 |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| WO2019059953A2 (en) | 2017-09-22 | 2019-03-28 | Otitopic Inc. | DRY POWDER COMPOSITIONS CONTAINING MAGNESIUM STEARATE |
| WO2022050230A1 (ja) * | 2020-09-03 | 2022-03-10 | 学校法人埼玉医科大学 | アデノシン受容体の活性化を抑制する組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003960D0 (en) * | 2000-02-18 | 2000-04-12 | Pfizer Ltd | Purine derivatives |
| TWI227240B (en) * | 2000-06-06 | 2005-02-01 | Pfizer | 2-aminocarbonyl-9H-purine derivatives |
-
2001
- 2001-12-06 GB GBGB0129270.5A patent/GB0129270D0/en not_active Ceased
-
2002
- 2002-11-28 DK DK02785778T patent/DK1455799T3/da active
- 2002-11-28 BR BR0214998-2A patent/BR0214998A/pt not_active IP Right Cessation
- 2002-11-28 EA EA200400639A patent/EA200400639A1/ru unknown
- 2002-11-28 JP JP2003548853A patent/JP2005513041A/ja active Pending
- 2002-11-28 AT AT02785778T patent/ATE293982T1/de not_active IP Right Cessation
- 2002-11-28 CN CNA028244168A patent/CN1856314A/zh active Pending
- 2002-11-28 DE DE60203934T patent/DE60203934T2/de not_active Expired - Fee Related
- 2002-11-28 PT PT02785778T patent/PT1455799E/pt unknown
- 2002-11-28 AU AU2002351066A patent/AU2002351066B2/en not_active Ceased
- 2002-11-28 AP APAP/P/2004/003082A patent/AP2004003082A0/en unknown
- 2002-11-28 AP APAP/P/2004/003053A patent/AP2004003053A0/en unknown
- 2002-11-28 OA OA1200400164A patent/OA12738A/en unknown
- 2002-11-28 WO PCT/IB2002/005057 patent/WO2003047598A1/en active Application Filing
- 2002-11-28 CA CA002469085A patent/CA2469085A1/en not_active Abandoned
- 2002-11-28 HU HU0402540A patent/HUP0402540A3/hu unknown
- 2002-11-28 NZ NZ533054A patent/NZ533054A/en unknown
- 2002-11-28 MX MXPA04005506A patent/MXPA04005506A/es active IP Right Grant
- 2002-11-28 EP EP02785778A patent/EP1455799B1/en not_active Expired - Lifetime
- 2002-11-28 KR KR1020047008609A patent/KR100685557B1/ko not_active IP Right Cessation
- 2002-11-28 ES ES02785778T patent/ES2239728T3/es not_active Expired - Lifetime
- 2002-11-28 PL PL02370739A patent/PL370739A1/xx not_active Application Discontinuation
- 2002-11-29 TW TW091134818A patent/TWI256388B/zh not_active IP Right Cessation
- 2002-12-03 PE PE2002001164A patent/PE20030834A1/es not_active Application Discontinuation
- 2002-12-03 HN HN2002000348A patent/HN2002000348A/es unknown
- 2002-12-04 AR ARP020104685A patent/AR037634A1/es unknown
- 2002-12-05 GT GT200200258A patent/GT200200258A/es unknown
- 2002-12-05 SV SV2002001426A patent/SV2004001426A/es not_active Application Discontinuation
- 2002-12-05 UY UY27566A patent/UY27566A1/es not_active Application Discontinuation
- 2002-12-06 PA PA20028560701A patent/PA8560701A1/es unknown
-
2004
- 2004-05-21 ZA ZA200403966A patent/ZA200403966B/xx unknown
- 2004-05-21 IS IS7280A patent/IS7280A/is unknown
- 2004-06-02 MA MA27710A patent/MA27150A1/fr unknown
- 2004-06-03 CO CO04052108A patent/CO5580752A2/es not_active Application Discontinuation
- 2004-06-04 EC EC2004005132A patent/ECSP045132A/es unknown
- 2004-06-04 TN TNP2004000101A patent/TNSN04101A1/fr unknown
- 2004-06-07 HR HR20040517A patent/HRP20040517A2/hr not_active Application Discontinuation
- 2004-07-05 NO NO20042839A patent/NO20042839L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0209986A (pt) | Agonista de a2a em combinação com um agente anticolinérgico, para o tratamento de doenças obstrutivas das vias respiratórias | |
| BRPI0514474A (pt) | multiparticulados | |
| BRPI0413563A (pt) | compostos e composições como inibidores de atividade do receptor de quìnase de tirosina | |
| CY1111797T1 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
| BRPI0614415A2 (pt) | método de indução de contracepção, terapia de reposição hormonal, tratamento de doença dependente de hormônio, sincronização de estro, ou tratamento de sintomas relacionados com ciclo em um mamífero, regime de contracepção, uso de um composto, composto, e, produto de contracepção | |
| WO2005084307A3 (en) | Use of lipid conjugates in the treatment of disease | |
| WO2007047372A3 (en) | Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists | |
| PL1699459T3 (pl) | Sposób leczenia stwardnienia rozsianego | |
| BRPI0507544A (pt) | combinação de agonistas de benzotiazol-2-ona beta-2 adrenoreceptores e corticosteróides para o tratamento de doenças respiratórias | |
| BR0214998A (pt) | Combinações farmacêuticas de agonistas do receptor da adenosina a-2a e do receptor adrenérgico beta-2 | |
| BR9908510A (pt) | Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana | |
| BR0200246A (pt) | Tratamento de combinação para a depressão | |
| BR0212329A (pt) | Métodos para tratar doença pulmonar | |
| BRPI0409588A (pt) | composto, composição farmacêutica, métodos para ligar seletivamente ao receptor beta de estrogênio em um paciente, para tratar um paciente acometido de uma condição de enfermidade mediada com um receptor beta de estrogênio, para tratar cáncer de próstata e hiperplasia prostática benigna em um paciente, e, uso de um composto | |
| BR0214776A (pt) | Combinação de um inibidor seletivo de pde4 e um agonista do receptor adrenérgico beta-2 | |
| ATE277639T1 (de) | Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten | |
| UY27565A1 (es) | Combinación farmacéutica. | |
| MX2007005525A (es) | Tratamiento terapeutico de resorcion ose acelerada. | |
| WO2007047575A3 (en) | Pharmacological treatments for sleep-related breathing disorders | |
| DE60008590D1 (de) | Zusammensetzungen von adenosin a1 agonisten und cox2-hemmern | |
| BR0210821A (pt) | Derivados de ácidos cicloalquilpirrol-3-carboxìlicos e derivados de ácidos heterocicloalquilpirrol-3-carboxìlicos | |
| DE60008589D1 (de) | Zusammensetzungen von adenosin a1 agonisten mit 5ht1 agonisten | |
| CO5690571A2 (es) | Combinacion sinergica que comprende roflumilas y (r,r)-formoterol | |
| CL2008001936A1 (es) | Composicion vacunal que comprende un conjugado quimico entre el factor de crecimiento epidermico humano recombinante (hregf) y la proteina recombinante rp64k; donde cada molecula de rp64k se enlaza 2 moleculas de hregf, con al menos un 90% de principio activo;procedimiento de obtencion; y su uso para tratar tumores de origen epitelial. | |
| SV2006002304A (es) | "azabenzoxazoles para el tratamiento de trastornos del snc" ref.pc32518a |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 8A. ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |